{"url_path":"/sec/nmra/8-k/2026-06-15/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1885522/0001193125-26-270328-index.html","accession_number":"0001193125-26-270328","cik":"0001885522","ticker":"NMRA","issuer_name":"Neumora Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1885522/0001193125-26-270328-index.html","primary_entity_key":"0001885522","primary_entity_name":"Neumora Therapeutics, Inc."},"word_count":38,"has_tables":true,"body_markdown":"Item 2.03.\n\nCreation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.\n\nThe description set forth under Item 1.01 of this Form 8-K is incorporated by reference herein in its entirety."}